| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
| mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.009 |